UAE Strengthens access to innovative care with New Fibrosis Drug Approval
The Emirates Drug Establishment has approved Jascayd® (nerandomilast) for the treatment of…
FDA approves Lilly’s EBGLYSS® for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis
The U.S. FDA has approved a new maintenance dosing regimen for Eli…
Harbour BioMed Announces NMPA Acceptance for the Treatment of Advanced Solid Tumors
Harbour BioMed has announced that China’s National Medical Products Administration (NMPA) has…
Mauna Kea Technologies Expands Presence in the Middle East with UAE and Turkey Regulatory Approvals and First CellTolerance® Commercial Installation
Mauna Kea Technologies has received regulatory approvals in the UAE and Turkey…
Thermo Fisher to Sell Microbiology Business to Astorg for $1.075 Billion
Thermo Fisher Scientific has agreed to sell its microbiology business to Astorg…
FDA Grants Breakthrough Therapy Designation to Novartis’ Ianalumab for Sjögren’s Disease
The FDA has granted Breakthrough Therapy designation to Novartis’ ianalumab for Sjögren’s…
The Emirates Drug Foundation approves gene therapy for gene replacement in a new age group of spinal muscular atrophy patients.
The Emirates Drug Authority (EDA) has announced the approval of Itvisma, a…
